Results 181 to 188 of about 2,105 (188)

Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma

Clinical Endocrinology, 2001
Smit, J. W., van Tol, K. M., Hew, J. M., Vielvoye, G. J., Romijn, J. A., Links, T. P.   +5 more
openaire   +4 more sources

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Journal of Neuro-Oncology, 2006
Vinay Puduvalli, Kurt Jaeckle, Mark Gilbert   +2 more
exaly  

Mixed response to new data on anticancer agent marimastat

Inpharma Weekly, 1997
openaire   +1 more source

Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease

British Journal of Surgery, 2002
Stephen Goodall, P R F Bell, M M Thompson   +2 more
exaly  

Batimastat and Marimastat in Cancer: Summary of Early Clinical Data

2003
openaire   +1 more source

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

British Journal of Clinical Pharmacology, 1998
exaly  

A PROCESS FOR THE PREPARATION OF MARIMASTAT, MARIMASTAT PREPARED BY THIS PROCESS, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USES THEREOF

PIKUL STANISŁAW, MASNYK MAREK, SIDORYK KATARZYNA, MUCHA ŁUKASZ, MAGDYCZ MARTA, PIASECKA SYLWIA   +5 more
openaire   +1 more source

CRYSTALLINE POLYMORPHIC FORMS OF MARIMASTAT, AN AMORPHOUS FORM OF MARIMASTAT, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

MASNYK MAREK, SIDORYK KATARZYNA, MUCHA ŁUKASZ, MAGDYCZ MARTA, TYSZKIEWICZ MAGDALENA, PIKUL STANISŁAW   +5 more
openaire   +1 more source